Bryan Johnson went viral several times before the recent release of his Netflix documentary “Don’t Die: The Man Who Wants to ...

NPR's A Martinez speaks with tech entrepreneur Bryan Johnson about the Netflix documentary "Don't Die: The Man That Wants To Live Forever," which portrays his quest to slow aging.

The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...

Biohacker Bryan Johnson has been drawing attention to his unconventional methods to "reverse" the aging process for years.

A tech millionaire famed for undertaking wild experiments in a bid to “not die” has published “intimate” details about his son. Bryan Johnson has amassed a huge following after he sold his ...

Another of those "heavy hitters" was Brian Johnson, the offensive coordinator the Eagles fired at the end of last season. Quinn had been following Johnson's path since the latter's days as the ...

Johnson & Johnson Q4 adjusted EPS of $2.04 beat the $2.01 consensus, with $22.52B in sales, up 5.3% year-over-year. MedTech sales rose 6.7% to $8.19B, while Darzalex sales surged 20.9% to $3.08B ...

On Wednesday, Johnson & Johnson (NYSE:JNJ) reported a fourth-quarter adjusted EPS of $2.04, down 10.9% year over year, beating the consensus of $2.01. The pharmaceutical giant reported sales of $ ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to ... especially if those pills aren't improving their symptoms and are causing undesirable side effects, such as weight ...

Johnson & Johnson said Monday it expects to accelerate sales growth beyond Wall Street expectations in the field of neuroscience with the $14.6 billion acquisition of Intra-Cellular Therapies Inc ...

Biohacker Bryan Johson claims to have turned back the ... his extreme “Project Blueprint” longevity plan. In the doc, Johnson, 47, claims that his intensive routine means he now ages slower ...